Women’s Health Diagnostic Testing Market is expected to witness an exponential growth over forecast year. The NIH Revitalization Act was formulated in 1993 with a vision to determine the best knowledge about gender and ethnicity differences and similarities and also made women health a national priority. Efforts are now made in order to ensure a healthy lifestyle for women to conform to the laid vision. In terms of healthcare and on a global scale, a high number of women suffer from diseases such as cardiovascular, lung cancer, depression, Alzheimer and urinary contingencies and owing to growth in medical infrastructure across the world and so a higher proportion of women get a timely diagnosis..
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/womens-health-diagnostic-testing-market/request-sample
The key driving factors responsible for the growth of Women’s Health
Diagnostic Testing market :
On a commercial basis, women have
distinctive health issues such as menopause, pregnancy and other minor ailments
pertaining to fertility. So, with the rise in number of female patients for
distinct diseases, the market for women’s health and diagnostic testing market
is gaining a positive traction which is likely to augment the market growth in
distant future.
The key driving factors
responsible for the growth of women’s health diagnostic testing market include
rising awareness in patients with regards to healthcare concerns, growing
research for detection of several type of cancers and prevention of disease.
Additionally, women’s health diagnostic market also witnesses a significant
growth during the forecast period owing to government initiatives and public
awareness campaigns.
Moreover, the market is rising
due to favorable reimbursement of medical policies and medical coverage for
diagnosis & treatment of disorders. However, factors such as patient’s
unwillingness for early screening which need heavy expenditures for detections,
risk over diagnosis and overtreatment, expensive MRI scans and medicines are
likely to impede the market growth during the forecast period.
On the basis of tests conducted,
the global women’s health diagnostic testing market is segmented into pregnancy
& ovulation, bone density testing, prenatal screening, mammography, pap
smears or cervical cancer screening, colposcopy, HPV testing, ovarian cancer, urinary
tract infections, cystic fibrosis, and autoimmune diseases. On the basis of
prostate cancer screening, the global women’s health diagnostic testing market
is segmented into hospitals, clinics, home healthcare, research labs,
diagnostics and imaging centers and cancer institutes.
North America leads the global
market owing to advanced healthcare infrastructure, growth in per-capita
income, emphasis on multinational device manufacturing companies and
enhancement of MNC’s. Europe is anticipated to grow during the forecast period
owing to growth in regulations by various medical organizations such as WHO.
Besides, increased funding in public and private sector is propelling the
market growth. APAC regions are anticipated to grow during the forecast period
owing to growth in healthcare scenarios in the regions such as India and China.
The key players in the global
women’s health diagnostic testing market include Nova Biomedical, Quest
Diagnostics Inc., Abbott Laboratories, GE Healthcare, Alere Inc., Hologic,
Inc.,F. Hoffmann-La Roche AG, Becton, PerkinElmer Inc., Dickinson and Company,
bioMérieux SA, Koninklijke Philips N.V, Siemens Healthcare Diagnostics
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/womens-health-diagnostic-testing-market
No comments:
Post a Comment